These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For The Quarterly Period Ended
March 31,
2025
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from
to
Commission File Number:
1-4639
CTS CORPORATION
(Exact name of registrant as specified in its charter)
IN
35-0225010
(State or other jurisdiction of
incorporation or organization)
(IRS Employer
Identification Number)
4925 Indiana Avenue
Lisle
IL
60532
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (
630
)
577-8800
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which Registered
Common stock, without par value
CTS
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of April 23, 2025:
29,843,811
.
CONDENSED CONSOLIDATED STATEM
ENTS OF
EARNINGS
- UNAUDITED
(In thousands, except per share amounts)
Three Months Ended
March 31,
March 31,
2025
2024
Net sales
$
125,769
$
125,750
Cost of goods sold
79,220
80,660
Gross margin
46,549
45,090
Selling, general and administrative expenses
23,623
22,260
Research and development expenses
6,190
6,601
Restructuring charges
451
1,693
Operating earnings
16,285
14,536
Other income (expense):
Interest expense
(
1,167
)
(
801
)
Interest income
447
1,386
Other income (expense), net
557
(
1,463
)
Total other expense, net
(
163
)
(
878
)
Earnings before income taxes
16,122
13,658
Income tax expense
2,755
2,539
Net earnings
$
13,367
$
11,119
Earnings per share:
Basic
$
0.45
$
0.36
Diluted
$
0.44
$
0.36
Basic weighted – average common shares outstanding:
30,013
30,742
Effect of dilutive securities
313
252
Diluted weighted – average common shares outstanding:
30,326
30,994
Cash dividends declared per share
$
0.04
$
0.04
See notes to unaudited condensed consolidated financial statements.
3
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF
COMPREHENSIVE EARNINGS
‑
UNAUDITED
(In thousands of dollars)
Three Months Ended
March 31,
March 31,
2025
2024
Net earnings
$
13,367
$
11,119
Other comprehensive earnings (loss):
Changes in fair market value of derivatives, net of tax
876
730
Changes in unrealized pension cost, net of tax
14
65
Cumulative translation adjustment, net of tax
4,648
(
2,121
)
Other comprehensive earnings (loss)
$
5,538
$
(
1,326
)
Comprehensive earnings
$
18,905
$
9,793
See notes to unaudited condensed consolidated financial statements.
4
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDA
TED BALANCE SHEETS
(In thousands of dollars)
(Unaudited)
March 31,
December 31,
2025
2024
ASSETS
Current Assets
Cash and cash equivalents
$
90,288
$
94,334
Accounts receivable, net
81,440
77,649
Inventories, net
53,883
52,312
Other current assets
17,928
17,879
Total current assets
243,539
242,174
Property, plant and equipment, net
93,786
94,357
Operating lease assets, net
22,624
22,939
Other Assets
Goodwill
203,355
201,304
Other intangible assets, net
161,934
163,882
Deferred income taxes
27,851
27,591
Other
12,439
13,180
Total other assets
405,579
405,957
Total Assets
$
765,528
$
765,427
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accounts payable
$
43,182
$
42,629
Operating lease obligations
4,339
4,719
Accrued payroll and benefits
12,813
15,754
Accrued expenses and other liabilities
32,100
35,361
Total current liabilities
92,434
98,463
Long-term debt
86,700
92,300
Long-term operating lease obligations
21,160
21,120
Long-term pension obligations
3,905
3,931
Deferred income taxes
13,230
12,743
Other long-term obligations
9,861
8,662
Total Liabilities
227,290
237,219
Commitments and Contingencies (Note 9)
Shareholders’ Equity
Common stock
324,635
321,979
Additional contributed capital
40,804
44,662
Retained earnings
665,017
652,851
Accumulated other comprehensive income (loss)
1,272
(
4,266
)
Total shareholders’ equity before treasury stock
1,031,728
1,015,226
Treasury stock
(
493,490
)
(
487,018
)
Total shareholders’ equity
538,238
528,208
Total Liabilities and Shareholders’ Equity
$
765,528
$
765,427
See notes to unaudited condensed consolidated financial statements.
5
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEME
NTS OF CASH FLOWS
‑
UNAUDITED
(In thousands of dollars)
Three Months Ended
March 31,
March 31,
2025
2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings
$
13,367
$
11,119
Adjustments to reconcile net earnings to net cash provided by operating
activities:
Depreciation and amortization
8,494
7,325
Pension and other post-retirement plan expense
177
84
Stock-based compensation
1,647
1,221
Deferred income taxes
(
491
)
(
621
)
Change in fair value of contingent consideration liability
(
162
)
(
253
)
Loss (gain) on foreign currency hedges, net of cash
168
(
299
)
Changes in assets and liabilities, net of acquisitions:
Accounts receivable
(
3,040
)
(
2,985
)
Inventories
(
1,022
)
1,656
Operating lease assets
315
1,135
Other assets
73
792
Accounts payable
765
2,835
Accrued payroll and benefits
(
3,352
)
(
1,273
)
Operating lease liabilities
(
340
)
(
1,136
)
Accrued expenses and other liabilities
(
1,041
)
(
1,247
)
Pension and other post-retirement plans
(
40
)
(
42
)
Net cash provided by operating activities
15,518
18,311
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures
(
4,465
)
(
4,035
)
Net cash used in investing activities
(
4,465
)
(
4,035
)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of long-term debt
(
264,200
)
(
167,500
)
Proceeds from borrowings of long-term debt
258,600
167,500
Purchases of treasury stock
(
6,465
)
(
11,958
)
Dividends paid
(
1,201
)
(
1,233
)
Taxes paid on behalf of equity award participants
(
2,634
)
(
3,117
)
Net cash used in financing activities
(
15,900
)
(
16,308
)
Effect of exchange rate changes on cash and cash equivalents
801
581
Net decrease in cash and cash equivalents
(
4,046
)
(
1,451
)
Cash and cash equivalents at beginning of period
94,334
163,876
Cash and cash equivalents at end of period
$
90,288
$
162,425
Supplemental cash flow information:
Cash paid for interest
$
1,060
$
739
Cash paid for income taxes, net
$
2,912
$
3,799
Non-cash financing and investing activities:
Capital expenditures incurred but not paid
$
1,049
$
1,733
Excise taxes on purchase of treasury stock incurred not paid
$
6
$
77
See notes to unaudited condensed consolidated financial statements.
6
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS O
F SHAREHOLDERS' EQUITY - UNAUDITED
(in thousands of dollars, except shares and per share amounts)
The following summarizes the changes in total equity for the three months ended March 31, 2025:
Common
Stock
Additional
Contributed
Capital
Retained
Earnings
Accumulated
Other
Comprehensive Income
(Loss)
Treasury
Stock
Total
Balances at December 31, 2024
$
321,979
$
44,662
$
652,851
$
(
4,266
)
$
(
487,018
)
$
528,208
Net earnings
—
—
13,367
—
—
13,367
Changes in fair market value of derivatives, net of tax
—
—
—
876
—
876
Changes in unrealized pension cost, net of tax
—
—
—
14
—
14
Cumulative translation adjustment, net of tax
—
—
—
4,648
—
4,648
Cash dividends of $
0.04
per share
—
—
(
1,201
)
—
—
(
1,201
)
Acquired
143,541
shares of treasury stock
—
—
—
—
(
6,472
)
(
6,472
)
Issued shares on vesting of restricted stock units
2,656
(
5,290
)
—
—
—
(
2,634
)
Stock compensation
—
1,432
—
—
—
1,432
Balances at March 31, 2025
$
324,635
$
40,804
$
665,017
$
1,272
$
(
493,490
)
$
538,238
See notes to unaudited condensed consolidated financial statements.
7
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - UNAUDITED
(in thousands of dollars, except shares and per share amounts)
The following summarizes the changes in total equity for the three months ended March 31, 2024:
Common
Stock
Additional
Contributed
Capital
Retained
Earnings
Accumulated
Other
Comprehensive Income
(Loss)
Treasury
Stock
Total
Balances at December 31, 2023
$
319,269
$
45,097
$
602,232
$
4,264
$
(
444,040
)
$
526,822
Net earnings
—
—
11,119
—
—
11,119
Changes in fair market value of derivatives, net of tax
—
—
—
730
—
730
Changes in unrealized pension cost, net of tax
—
—
—
65
—
65
Cumulative translation adjustment, net of tax
—
—
—
(
2,121
)
—
(
2,121
)
Cash dividends of $
0.04
per share
—
—
(
1,227
)
—
—
(
1,227
)
Acquired
271,939
shares of treasury stock
—
—
—
—
(
12,035
)
(
12,035
)
Issued shares on vesting of restricted stock units
2,589
(
5,705
)
—
—
—
(
3,116
)
Stock compensation
—
1,048
—
—
—
1,048
Balances at March 31, 2024
$
321,858
$
40,440
$
612,124
$
2,938
$
(
456,075
)
$
521,285
See notes to unaudited condensed consolidated financial statements.
8
NOTES TO CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS - UNAUDITED
(in thousands except for share and per share data)
March 31, 2025
NOTE 1 — Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared by CTS Corporation (“CTS”, “we”, “our”, “us” or the “Company”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the financial statements, notes thereto, and other information included in the Company’s Annual Report on Form 10‑K for the year ended
December 31, 2024.
The accompanying unaudited condensed consolidated financial statements reflect, in the opinion of management, all adjustments (consisting of normal recurring items) necessary for a fair statement, in all material respects, of the financial position and results of operations for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ materially from those estimates. The results of operations for the interim periods are not necessarily indicative of the results for the entire year.
There have been no material changes in the Company’s significant accounting policies as compared to the significant accounting policies described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Immaterial Correction of Prior Period Error
The Company identified immaterial prior period errors in the consolidated financial statements related to the acquisition of SyQwest, LLC (“SyQwest”) as well as the foreign currency impact on certain long-term debt payments. The errors related to the SyQwest acquisition were due to errors with the calculation of revenue and cost of goods sold both prior to and subsequent to the acquisition date of July 29, 2024. The Company assessed the materiality of this change on prior period consolidated financial statements in accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” (ASC Topic 250, Accounting Changes and Error Corrections). Based on this assessment, the Company concluded that these error corrections were material in the current period, but are not material to any previously presented consolidated financial statements. Accordingly, the Company corrected the previously reported immaterial errors for the year ended December 31, 2024 and the three and nine months ended September 30, 2024 in this Quarterly Report on Form 10-Q.
The financial reporting periods affected by this error include the Company’s previously reported audited consolidated financial statements for the fiscal year ended December 31, 2024 and the Company’s previously reported interim unaudited consolidated financial statements for the three and nine months ended September 30, 2024. In addition, the Company expects to present the corrected interim 2024 amounts in its 2025 consolidated interim financial statements upon the filing of each of its Quarterly Reports on Form 10-Q on a year-to-date basis as a correction to applicable 2024 periods. A summary of the immaterial corrections to the Company’s previously reported audited and unaudited consolidated financial statements follows.
9
Corrected Consolidated Statement of Earnings for the Year Ended December 31, 2024 (in thousands):
Year Ended
Year Ended
December 31, 2024
December 31, 2024
Previously Reported
Corrections
As Corrected
Net sales
$
515,771
$
(
1,015
)
$
514,756
Cost of goods sold
326,621
580
327,201
Gross margin
189,150
(
1,595
)
187,555
Operating earnings
72,780
(
1,595
)
71,185
Other income (expense):
Other income (expense), net
(
1,603
)
(
1,047
)
(
2,650
)
Total other expense, net
(
1,557
)
(
1,047
)
(
2,604
)
Earnings before income taxes
71,223
(
2,642
)
68,581
Net earnings
$
58,114
$
(
2,642
)
$
55,472
Earnings per share:
Basic
$
1.91
$
1.82
Diluted
$
1.89
$
1.81
Basic weighted – average common shares outstanding:
30,408
30,408
Effect of dilutive securities
309
309
Diluted weighted – average common shares outstanding:
30,717
30,717
Corrected Consolidated Balance Sheet as of December 31, 2024 (in thousands):
December 31, 2024
December 31, 2024
Previously Reported
Corrections
As Corrected
ASSETS
Current Assets
Inventories, net
$
53,578
$
(
1,266
)
$
52,312
Other current assets
18,716
(
837
)
17,879
Total current assets
244,277
(
2,103
)
242,174
Other Assets
Goodwill
199,886
1,418
201,304
Total other assets
404,539
1,418
405,957
Total Assets
$
766,112
$
(
685
)
$
765,427
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accrued expenses and other liabilities
34,451
910
35,361
Total current liabilities
97,553
910
98,463
Long-term debt
91,253
1,047
92,300
Total Liabilities
235,262
1,957
237,219
Shareholders’ Equity
Retained earnings
655,493
(
2,642
)
652,851
Total shareholders’ equity before treasury stock
1,017,868
(
2,642
)
1,015,226
Total shareholders’ equity
530,850
(
2,642
)
528,208
Total Liabilities and Shareholders’ Equity
$
766,112
$
(
685
)
$
765,427
10
Corrected Consolidated Statement of Cash Flows for the Year Ended December 31, 2024 (in thousands):
Year Ended
Year Ended
December 31, 2024
December 31, 2024
Previously Reported
Corrections
As Corrected
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings
$
58,114
$
(
2,642
)
$
55,472
Changes in assets and liabilities, net of acquisitions:
Inventories
11,893
580
12,473
Other assets
900
837
1,737
Accrued expenses and other liabilities
(
5,255
)
178
(
5,077
)
Net cash provided by operating activities
99,289
(
1,047
)
98,242
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of long-term debt
(
891,847
)
1,047
(
890,800
)
Net cash (used in) provided by financing activities
$
(
27,935
)
$
1,047
$
(
26,888
)
Corrected Consolidated Statement of Earnings for the Three and Nine Months Ended September 30, 2024 (in thousands):
Three Months Ended
Three Months Ended
Nine Months Ended
Nine Months Ended
September 30, 2024
September 30, 2024
September 30, 2024
September 30, 2024
Previously Reported
Corrections
As Corrected
Previously Reported
Corrections
As Corrected
Net sales
$
132,424
$
(
40
)
$
132,385
$
388,336
$
(
40
)
$
388,296
Cost of goods sold
82,636
559
83,195
247,086
559
247,645
Gross margin
49,788
(
599
)
49,189
141,250
(
599
)
140,651
Operating earnings
21,475
(
599
)
20,876
53,775
(
599
)
53,176
Earnings before income taxes
22,447
(
599
)
21,848
53,872
(
599
)
53,273
Net earnings
$
18,683
$
(
599
)
$
18,084
$
44,508
$
(
599
)
$
43,909
Earnings per share:
Basic
$
0.62
$
0.60
$
1.46
$
1.44
Diluted
$
0.61
$
0.59
$
1.45
$
1.43
Basic weighted – average common shares outstanding:
30,300
30,300
30,517
30,517
Effect of dilutive securities
236
236
230
230
Diluted weighted – average common shares outstanding:
30,536
30,536
30,747
30,747
11
Corrected Consolidated Balance Sheet as of September 30, 2024 (in thousands):
September 30, 2024
September 30, 2024
Previously Reported
Corrections
As Corrected
ASSETS
Current Assets
Inventories, net
$
57,288
$
(
1,246
)
$
56,042
Total current assets
255,561
(
1,246
)
254,315
Other Assets
Goodwill
194,821
1,418
196,239
Total other assets
416,677
1,418
418,095
Total Assets
$
789,392
$
172
$
789,564
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accrued expenses and other liabilities
37,249
771
38,020
Total current liabilities
103,799
771
104,570
Total Liabilities
258,586
771
259,357
Shareholders’ Equity
Retained earnings
643,088
(
599
)
642,489
Total shareholders’ equity before treasury stock
1,009,937
(
599
)
1,009,338
Total shareholders’ equity
530,806
(
599
)
530,207
Total Liabilities and Shareholders’ Equity
$
789,392
$
172
$
789,564
Corrected Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2024 (in thousands):
Nine Months Ended
Nine Months Ended
September 30, 2024
September 30, 2024
Previously Reported
Corrections
As Corrected
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings
$
44,508
$
(
599
)
$
43,909
Changes in assets and liabilities, net of acquisitions:
Inventories
11,346
559
11,905
Accrued expenses and other liabilities
(
2,645
)
40
(
2,605
)
Net cash provided by operating activities
$
73,335
$
-
$
73,335
Corrected Fair Value of SyQwest Assets Acquired and Liabilities Assumed:
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments' significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as existing segment disclosures and reconciliation required under ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for the interim periods beginning after December 15, 2024, with early adoption permitted. We adopted the guidance in our Annual Report on Form 10-K for the year ended December 31, 2024. See Note 17, “Segment Information,” for further information.
Recently issued accounting pronouncements not yet adopted
ASU No. 2023-09, “
Income Taxes (Topic 740): Improvements to Income Tax Disclosures”
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the reconciliation of the effective tax rate, as well as disclosure of income taxes paid, disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09. We will adopt the guidance when it becomes effective on a prospective basis.
ASU No. 2024-03, “
Income Statement (Subtopic 220-40): Disaggregation of Income Statement Expenses”
In November 2024, the FASB issued ASU 2024-03, Income Statement (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires additional information about certain expenses in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03. We will adopt the guidance when it becomes effectiv
e on a prospective basis.
NOTE 2 – Revenue Recognition
CTS designs and manufactures sensors, actuators, and electronic components for original equipment manufacturers and the U.S. Government. For each contract with a customer, we determine the transaction price based on the consideration expected to be received by the Company in exchange for performing its obligations under the applicable contract. We allocate the transaction price to each distinct performance obligation to deliver a good or service, or a collection of goods and/or services, based on the relative standalone selling prices. We usually expect payment from our customers within 30 to 90 days from the shipping date or invoicing date, depending on our terms with the customer. None of our contracts as of March 31, 2025 contained a significant financing component. Differences between the amount of revenue recognized and the amount invoiced, collected from, or paid to our customers are recognized as contract assets or liabilities. Contract assets will be reviewed for impairment when events or circumstances indicate that they may not be recoverable.
To the extent the transaction price includes variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing the most likely value method based on an analysis of historical experience and current facts and circumstances, which may require significant judgment. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur.
The majority of our revenue is derived from contracts for sales of commercial products, which generally contain a single performance obligation. We generally recognize revenue at a point in time on the delivery date based on the shipping terms stipulated in the contract.
We also design, manufacture, and test products for certain customers under contracts that allow the customers to unilaterally terminate the contract for convenience, take control of any work in process, and pay us for costs incurred plus a reasonable profit. Revenue from these contracts is generally recognized over time as the work progresses, either as products are produced or services are rendered, because we generally do not have an alternative use for the completed assets produced and we have an enforceable right to payment for performance completed to date. These contracts may contain a single or multiple performance obligations. The accounting for these contracts involves applying significant judgment with respect to estimating total revenues, costs and profit for each performance
13
obligation. We generally estimate revenue for these contracts using the costs incurred by the Company as we have determined it is most representative of the Company's cumulative efforts relative to the total expected efforts to satisfy the performance obligations.
See Note 9, “Commitments and Contingencies” for information about our product warranties.
Contract Assets and Liabilities
Contract assets and liabilities included in our Condensed Consolidated Balance Sheets are as follows:
As of
March 31,
December 31,
2025
2024
Contract Assets
Unbilled customer receivables included in Other current assets
$
3,687
$
4,104
Total Contract Assets
$
3,687
$
4,104
Contract Liabilities
Customer advance payments included in Accrued expenses and other liabilities
$
(
850
)
$
(
910
)
Total Contract Liabilities
$
(
850
)
$
(
910
)
During the three months ended March 31, 2025 the Company recognized $
60
of revenue that was included in the contract liability balance at December 31, 2024.
Disaggregated Revenue
The following table presents revenues disaggregated by the major markets we serve:
Three months ended
March 31, 2025
March 31, 2024
Transportation
$
58,489
$
66,516
Industrial
32,448
31,064
Medical
19,131
16,901
Aerospace & Defense
15,701
11,269
Total
$
125,769
$
125,750
NOTE 3 – Accounts Receivable, net
The components of accounts receivable, net are as follows:
As of
March 31,
December 31,
2025
2024
Accounts receivable, gross
$
82,235
$
78,379
Less: Allowance for credit losses
(
795
)
(
730
)
Accounts receivable, net
$
81,440
$
77,649
As of
March 31,
December 31,
2024
2023
Accounts receivable, gross
$
81,389
$
79,500
Less: Allowance for credit losses
(
726
)
(
931
)
Accounts receivable, net
$
80,663
$
78,569
14
NOTE 4 – Inventories, net
Inventories, net consists of the following:
As of
March 31,
December 31,
2025
2024
Finished goods
$
11,886
$
12,126
Work-in-process
24,365
22,331
Raw materials
31,341
31,818
Less: Inventory reserves
(
13,709
)
(
13,963
)
Inventories, net
$
53,883
$
52,312
NOTE 5 – Property, Plant and Equipment, net
Property, plant and equipment, net is comprised of the following:
As of
March 31,
December 31,
2025
2024
Land and land improvements
$
399
$
399
Buildings and improvements
73,165
73,011
Machinery and equipment
269,068
265,950
Less: Accumulated depreciation
(
248,846
)
(
245,003
)
Property, plant and equipment, net
$
93,786
$
94,357
Depreciation expense for the three months ended March 31, 2025 and March 31, 2024 was $
4,463
and $
4,500
, respectively.
NOTE 6 – Goodwill and Other Intangible Assets
Goodwill
Changes in the net carrying amount of goodwill were as follows:
Total
Goodwill as of December 31, 2024
$
201,304
Foreign exchange impact
2,051
Goodwill as of March 31, 2025
$
203,355
Other Intangible Assets
Other intangible assets, net consist of the following components:
As of
March 31, 2025
Gross
Carrying
Amount
Accumulated
Amortization
Net Amount
Customer lists/relationships
$
212,694
$
(
76,109
)
$
136,585
Technology and other intangibles
61,562
(
36,213
)
25,349
Other intangible assets, net
$
274,256
$
(
112,322
)
$
161,934
15
As of
December 31, 2024
Gross
Carrying
Amount
Accumulated
Amortization
Net Amount
Customer lists/relationships
$
210,354
$
(
72,500
)
$
137,854
Technology and other intangibles
61,244
(
35,216
)
26,028
Other intangible assets, net
$
271,598
$
(
107,716
)
$
163,882
Amortization expense for the three months ended March 31, 2025 and March 31, 2024 was $
4,031
and $
2,825
, respectively. The changes in the gross carrying amounts of intangible assets are due to foreign exchange impacts in the quarter.
Remaining amortization expense for other intangible assets as of
March 31, 2025 is as follows:
Amortization
expense
Remaining 2025
$
11,971
2026
15,855
2027
15,794
2028
15,759
2029
14,590
Thereafter
87,965
Total amortization expense
$
161,934
NOTE 7 – Costs Associated with Exit and Restructuring Activities
Restructuring charges are reported as a separate line within operating earnings in the Condensed Consolidated Statements of Earnings.
Total restructuring charges are as follows:
Three Months Ended
March 31, 2025
March 31, 2024
Restructuring charges
$
451
$
1,693
During the period ended March 31, 2025, we incurred total restructuring charges of $
451
, comprised of $
393
, $
21
, and $
37
in workforce reduction, building and equipment relocation costs, and asset impairment and other charges, respectively. The workforce reduction charges incurred are for restructuring activities used to adjust our business in response to reduced demand across certain locations and products. Restructuring charges incurred in relation to building and equipment relocation costs and other charges are for activities intended to consolidate operations across our site locations. The remaining liability associated with our other restructuring actions was $
738
and $
798
at
March 31, 2025 and December 31, 2024, respectively.
The following table displays the restructuring liability activity included in accrued expenses and other liabilities for the
three months ended March 31, 2025:
Restructuring liability at December 31, 2024
$
798
Restructuring charges
451
Costs paid
(
511
)
Restructuring liability at March 31, 2025
$
738
16
NOTE 8 – Accrued Expenses and Other Liabilities
The components of accrued expenses and other liabilities are as follows:
As of
March 31,
December 31,
2025
2024
Accrued product-related costs
$
2,267
$
1,866
Accrued income taxes
5,506
5,418
Accrued property and other taxes
1,508
1,518
Accrued professional fees
1,760
1,625
Accrued customer-related liabilities
1,704
2,113
Dividends payable
1,199
1,201
Remediation reserves
12,035
12,192
Derivative liabilities
1,819
334
Other accrued liabilities
4,302
9,094
Total accrued expenses and other liabilities
$
32,100
$
35,361
NOTE 9 – Commitments and Contingencies
Certain processes in the manufacture of our current and past products may create by-products classified as hazardous waste. As a result, we have been notified by the U.S. Environmental Protection Agency (“EPA”), state environmental agencies and in some cases, groups of potentially responsible parties, that we may be potentially liable for environmental contamination at several sites currently or formerly owned or operated by us. Currently, none of these costs and accruals relate to sites that provide revenue generating activities for the Company.
Two
of those sites, Asheville, North Carolina (the “Asheville Site”) and Mountain View, California, are designated National Priorities List sites under the EPA’s Superfund program. We accrue a liability for probable remediation activities, claims, and proceedings against us with respect to environmental matters if the amount can be reasonably estimated, and provide disclosures including the nature of a loss whenever it is probable or reasonably possible that a potentially material loss may have occurred but cannot be estimated. We record contingent loss accruals on an undiscounted basis.
A roll-forward of remediation reserves included in accrued expenses and other liabilities on the Condensed Consolidated Balance Sheets is comprised of the following:
As of
March 31,
December 31,
2025
2024
Balance at beginning of period
$
12,192
$
12,044
Remediation expense
225
1,701
Net remediation payments
(
388
)
(
1,554
)
Other activity
(1)
6
1
Balance at end of the period
$
12,035
$
12,192
(1)
Other activity includes currency translation adjustments not recorded through remediation expense.
The Company operates under and in accordance with a federal consent decree, dated March 7, 2017, with the EPA for the Asheville Site. On February 8, 2023, the Company received a letter from the EPA (the “EPA Letter”) seeking reimbursement of its past response costs and interest thereon relating to any release or threatened release of hazardous substances at the Asheville Site in the aggregate amount of $
9,955
from the three potentially responsible parties associated with the Asheville Site, including the Company. The Company expects its potential exposure to be between $
1,900
and $
9,955
. We have determined that no point within this range is more likely than another and therefore we have recorded a loss estimate of $
1,900
as of March 31, 2025 and December 31, 2024 in the Consolidated Balance Sheets.
Unrelated to the environmental claims described above, certain other legal claims are pending against us with respect to matters arising out of the ordinary conduct of our business.
17
We provide product warranties when we sell our products and accrue for estimated liabilities at the time of sale. Warranty estimates are forecasts based on the best available information and historical claims experience. We accrue for specific warranty claims if we believe that the facts of a specific claim make it probable that a liability in excess of our historical experience has been incurred and provide disclosures for specific claims whenever it is reasonably possible that a material loss may be incurred which cannot be estimated.
We cannot provide assurance that the ultimate disposition of environmental, legal, and product warranty claims will not materially exceed the amount of our accrued losses and adversely impact our consolidated financial position, results of operations, or cash flows. Our accrued liabilities and disclosures will be adjusted accordingly if additional information becomes available in the future.
NOTE 10 - Debt
Long-term debt is comprised of the following:
As of
March 31,
December 31,
2025
2024
Total credit facility
$
400,000
$
400,000
Balance outstanding
86,700
92,300
Standby letters of credit
1,640
1,640
Amount available, subject to covenant restrictions
$
311,660
$
306,060
Weighted-average interest rate
5.70
%
6.41
%
On December 15, 2021, we entered into a second amended and restated
five-year
credit agreement with a group of banks (the “Revolving Credit Facility”) to (i) increase the total credit facility to $
400,000
, which may be increased by $
200,000
at the request of the Company, subject to the administrative agent's approval, (ii) extend the maturity of the Revolving Credit Facility from
February 12, 2024
to
December 15, 2026
, (iii) replace LIBOR with SOFR as the primary reference rate used to calculate interest on the loans under the Revolving Credit Facility, (iv) increase available sub limits for letters of credit and swingline loans as well as providing for additional alternative currency borrowing capabilities, and (v) modify the financial and non-financial covenants to provide the Company additional flexibility. This unsecured credit facility replaced the prior $
300,000
unsecured credit facility, which would have expired February 12, 2024.
Borrowings in U.S. dollars under the Revolving Credit Facility bear interest, at a per annum rate equal to the applicable Term SOFR rate (but not less than
0.0
%), plus the Term SOFR adjustment, and plus an applicable margin, which ranges from
1.00
%
to
1.75
%
, based on our net leverage ratio. Similarly, borrowings of alternative currencies under the Revolving Credit Facility bear interest equal to a defined risk-free reference rate, plus the applicable risk-free rate adjustment and plus an applicable margin, which ranges from
1.00
%
to
1.75
%
, based on our net leverage ratio. We use interest rate swaps to convert a portion of our revolving credit facility's outstanding balance from a variable rate of interest to a fixed rate. The contractual rate of these arrangements ranges from
1.49
%
to
2.45
%
. Refer to Note 11, “Derivative Financial Instruments,” for further discussion on the impact of interest rate swaps.
The Revolving Credit Facility includes a swingline sublimit of $
20,000
and a letter of credit sublimit of $
20,000
. We also pay a quarterly commitment fee on the unused portion of the Revolving Credit Facility. The commitment fee ranges from
0.175
%
to
0.25
%
based on our net leverage ratio.
The Revolving Credit Facility requires, in addition to customary representations and warranties, that we comply with a maximum net leverage ratio and a minimum interest coverage ratio. Failure to comply with these covenants could reduce the borrowing availability under the Revolving Credit Facility. We were in compliance with all debt covenants at March 31, 2025. The Revolving Credit Facility requires that we deliver quarterly financial statements, annual financial statements, auditor certifications, and compliance certificates within a specified number of days after the end of a quarter and year. Additionally, the Revolving Credit Facility contains restrictions limiting our ability to: dispose of assets; incur certain additional debt; repay other debt or amend subordinated debt instruments; create
18
liens on assets; make investments, loans or advances; make acquisitions or engage in mergers or consolidations; engage in certain transactions with our subsidiaries and affiliates; and make stock repurchases and dividend payments.
We have debt issuance costs related to our long-term debt that are being amortized using the straight-line method over the life of the debt, which approximates the effective interest method. Amortization expense for the three months ended March 31, 2025 and March 31, 2024 were $
48
and $
48
, respectively. These costs are included in interest expense in our Consolidated Statements of Earnings.
Note 11 - Derivative Financial Instruments
Our earnings and cash flows are subject to fluctuations due to changes in foreign currency exchange rates and interest rates. We selectively use derivative financial instruments including foreign currency forward contracts as well as interest rate and cross-currency swaps to manage our exposure to these risks.
The use of derivative financial instruments exposes the Company to credit risk, which relates to the risk of nonperformance by a counterparty to the derivative contracts. We manage our credit risk by entering into derivative contracts with only highly rated financial institutions and by using netting agreements.
The effective portion of derivative gains and losses are recorded in accumulated other comprehensive income (loss) until the hedged transaction affects earnings upon settlement, at which time they are reclassified to cost of goods sold or net sales. If it is probable that an anticipated hedged transaction will not occur by the end of the originally specified time period, we reclassify the gains or losses related to that hedge from accumulated other comprehensive income (loss) to other income (expense), net.
We assess hedge effectiveness qualitatively by verifying that the critical terms of the hedging instrument and the forecasted transaction continue to match, and that there have been no adverse developments that have increased the risk that the counterparty will default.
No
recognition of ineffectiveness was recorded in our Condensed Consolidated Statements of Earnings for the
three months ended March 31, 2025.
Foreign Currency Hedges
We use forward contracts to mitigate currency risk related to a portion of our forecasted foreign currency revenues and costs. The currency forward contracts are designed as cash flow hedges and are recorded in the Condensed Consolidated Balance Sheets at fair value.
We continue to monitor the Company’s overall currency exposure and may elect to add cash flow hedges in the future. At March 31, 2025, we had a net unrealized loss of $
1,659
in accumulated other comprehensive income (loss), $
1,723
of which is expected to be reclassified to earnings within the next 12 months. The notional amount of foreign currency forward contracts outstanding was $
65,527
at March 31, 2025.
Interest Rate Swaps
We use interest rate swaps to convert a portion of our Revolving Credit Facility’s outstanding balance from a variable rate of interest to a fixed rate. As of March 31, 2025
, we have agreements to fix interest rates on $
50,000
of long-term debt until December 2026. The difference to be paid or received under the terms of the swap agreements will be recognized as an adjustment to interest expense when settled.
These swaps are treated as cash flow hedges and, consequently, the changes in fair value are recorded in other comprehensive (loss) income. The estimated net amount of the existing gains that are reported in accumulated other comprehensive income (loss) that are expected to be reclassified into earnings within the next twelve months is approximately $
710
.
19
Cross-Currency Swap
The Company has operations and investments in various international locations and is subject to risks associated with changing foreign exchange rates. In order to hedge the Krone-based purchase price for the acquisition of Ferroperm Piezoceramics, A.S. (“Ferroperm”), the Company entered into a cross currency interest rate swap agreement on June 27, 2022 that synthetically swapped $
25,000
of variable rate debt to Krone-denominated variable rate debt. Upon completion of the Ferroperm acquisition on June 30, 2022, the transaction was designated as a net investment hedge for accounting purposes and will mature on
June 30, 2027
.
Accordingly, any gains or losses on this derivative instrument are included in the foreign currency translation component of other comprehensive (loss) income until the net investment is sold, diluted or liquidated. As of March 31, 2025, we had a net unrealized loss of $
606
in accumulated other comprehensive income (loss). Interest payments received for the cross-currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense in the Condensed Consolidated Statements of Earnings. The assumptions used in measuring fair value of the cross-currency swap are considered level 2 inputs, which are based upon the Krone to U.S. Dollar exchange rate market.
The location and fair values of derivative instruments designated as hedging instruments in the Condensed Consolidated Balance Sheets as of
March 31, 2025, are shown in the following table:
As of
March 31,
December 31,
2025
2024
Interest rate swaps reported in
Other current assets
$
710
$
792
Interest rate swaps reported in
Other assets
366
711
Cross-currency swap reported in Other current assets
-
324
Cross-currency swap reported in Accrued expenses and other liabilities
(
226
)
-
Foreign currency hedges reported in Accrued expenses and other liabilities
(
1,593
)
(
2,992
)
The Company has elected to net its foreign currency derivative assets and liabilities in the balance sheet in accordance with ASC 210-20 (
Balance Sheet, Offsetting
). On a gross basis, there were foreign currency derivative assets of $
221
and $
1,814
foreign currency derivative liabilities at March 31, 2025.
The effect of derivative instruments on the Condensed Consolidated Statements of Earnings is as follows:
Three Months Ended
March 31,
March 31,
2025
2024
Foreign Exchange Contracts:
Amounts reclassified from AOCI to earnings:
Net sales
$
(
40
)
$
26
Cost of goods sold
(
631
)
758
Total net (loss) gain reclassified from AOCI to earnings
(
671
)
784
Total derivative (loss) gain on foreign exchange contracts recognized in earnings
$
(
671
)
$
784
Interest Rate Swaps:
Income recorded in Interest expense
$
234
$
405
Cross-Currency Swap:
Income recorded in Interest expense
$
72
$
94
Total net (loss) gain on derivatives
$
(
365
)
$
1,283
20
NOTE 12 – Accumulated Other Comprehensive Income (Loss)
Shareholders’ equity includes certain items classified as accumulated other comprehensive income (loss) (“AOCI”) in the Condensed Consolidated Balance Sheets, including:
•
Unrealized gains (losses) on hedges
relate to interest rate swaps to convert a portion of our Revolving Credit Facility's outstanding balance from a variable rate of interest into a fixed rate, foreign currency forward contracts used to hedge our exposure to changes in exchange rates affecting certain revenues and costs denominated in foreign currencies, as well as a cross-currency swap that synthetically converts our U.S. Dollar variable rate debt to Krone-denominated variable rate debt. These hedges are designated as cash flow hedges, and we have deferred income statement recognition of gains and losses until the hedged transactions occur, at which time amounts are reclassified into earnings. Further information related to our derivative financial instruments is included in Note 11, “Derivative Financial Instruments” and Note 15, “Fair Value Measurements.”
•
Unrealized gains (losses) on pension obligations
are deferred from income statement recognition until the gains or losses are realized. Amounts reclassified to income from AOCI are included in net periodic pension income (expense).
•
Cumulative translation adjustments
relate to our non-U.S. subsidiary companies that have designated a functional currency other than the U.S. Dollar. We are required to translate the subsidiary functional currency financial statements to dollars using a combination of historical, period-end, and average foreign exchange rates. This combination of rates creates the foreign currency translation adjustment component of other comprehensive income (loss).
Changes in exchange rates between the functional currency and the currency in which a transaction is denominated are foreign exchange transaction gains or losses. Transaction losses for the three months ended March 31, 2025 and March 31, 2024 were $
513
and $
1,507
, respectively. The impact of these changes have been included in other income (expense) in the Condensed Consolidated Statements of Earnings.
The components of accumulated other comprehensive income (loss) for the
three months ended March 31, 2025, are as follows:
(Gain) Loss
As of
Gain (Loss)
Reclassified
As of
December 31,
Recognized
from AOCI
March 31,
2024
in OCI
to Earnings
2025
Changes in fair market value of derivatives:
Gross
$
(
1,730
)
$
708
$
437
$
(
585
)
Income tax benefit (expense)
397
(
166
)
(
103
)
128
Net
(
1,333
)
542
334
(
457
)
Changes in unrealized pension cost:
Gross
(
409
)
—
14
(
395
)
Income tax benefit (expense)
300
—
—
300
Net
(
109
)
—
14
(
95
)
Cumulative translation adjustment:
Gross
(
2,824
)
4,648
—
1,824
Income tax benefit (expense)
—
—
—
—
Net
(
2,824
)
4,648
—
1,824
Total accumulated other comprehensive (loss) income
$
(
4,266
)
$
5,190
$
348
$
1,272
21
The components of accumulated other comprehensive income (loss) for the three months ended March 31, 2024, are as follows:
(Gain) Loss
As of
Gain (Loss)
Reclassified
As of
December 31,
Recognized
from AOCI
March 31,
2023
in OCI
to Earnings
2024
Changes in fair market value of derivatives:
Gross
$
3,252
$
2,138
$
(
1,189
)
$
4,201
Income tax (expense) benefit
(
749
)
(
492
)
274
(
967
)
Net
2,503
1,646
(
915
)
3,234
Changes in unrealized pension cost:
Gross
(
1,126
)
—
69
(
1,057
)
Income tax benefit (expense)
442
—
(
5
)
437
Net
(
684
)
—
64
(
620
)
Cumulative translation adjustment:
Gross
2,445
(
2,121
)
—
324
Income tax benefit (expense)
—
—
—
—
Net
2,445
(
2,121
)
—
324
Total accumulated other comprehensive income (loss)
$
4,264
$
(
475
)
$
(
851
)
$
2,938
NOTE 13 – Shareholders’ Equity
Share count and par value data related to shareholders’ equity are as follows:
As of
March 31,
December 31,
2025
2024
Preferred Stock
Par value per share
No
par value
No
par value
Shares authorized
25,000,000
25,000,000
Shares outstanding
—
—
Common Stock
Par value per share
No
par value
No
par value
Shares authorized
75,000,000
75,000,000
Shares issued
57,620,771
57,543,964
Shares outstanding
29,959,311
30,026,045
Treasury stock
Shares held
27,661,460
27,517,919
On February 2, 2024, our Board of Directors approved a share repurchase program that authorizes the Company to repurchase up to $
100,000
of its common stock. The repurchase program has no set expiration date and supersedes and replaces the repurchase program approved by the Board of Directors in February 2023. The purchases may be made from time to time in the open market (including, without limitation, through the use of Rule 10b5-1 plans), depending on a number of factors, including our evaluation of general market and economic conditions, our financial condition and the trading price of our common stock. The repurchase program may be extended, modified, suspended or discontinued at any time.
During the three months ended March 31, 2025,
143,541
shares of common stock were repurchased for $
6,650
under the 2024 repurchase program. During the three months ended March 31, 2024,
271,939
shares of common stock were repurchased for $
12,078
. As of March 31, 2025, approximately $
54,772
remains available for future purchases.
We are subject to a 1% excise tax on stock repurchases under the United States Inflation Reduction Act of 2022 which we include in the cost of stock repurchases as a reduction of shareholders’ equity. As of March 31, 2025 and December 31, 2024, we had $
6
and $
741
, respectively, recorded in Accrued expenses and other liabilities in the Consolidated Balance Sheet.
22
A roll-forward of shares of common stock outstanding is as follows:
Three Months Ended
March 31,
March 31,
2025
2024
Balance at the beginning of the year
30,026,045
30,824,248
Repurchases
(
143,541
)
(
271,939
)
Restricted share issuances
76,807
96,790
Balance at the end of the period
29,959,311
30,649,099
Certain potentially dilutive restricted stock units are excluded from diluted earnings per share because they are anti-dilutive. The number of outstanding awards that were anti-dilutive for the three months ended March 31, 2025 and March 31, 2024 were
165
and
30,030
, respectively.
NOTE 14- Stock-Based Compensation
At March 31, 2025
, we had
five
active stock-based compensation plans: the Non-Employee Directors’ Stock Retirement Plan (“Directors’ Plan”), the 2004 Omnibus Long-Term Incentive Plan (“2004 Plan”), the 2009 Omnibus Equity and Performance Incentive Plan (“2009 Plan”), the 2014 Performance and Incentive Compensation Plan (“2014 Plan”), and the 2018 Equity and Incentive Compensation Plan (“2018 Plan”). Future grants can only be made under the 2018 Plan.
The 2018 Plan allows for grants of stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance shares, performance units, and other stock awards subject to the terms of the 2018 Plan.
The following table summarizes the compensation expense included in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings related to stock-based compensation plans:
Three Months Ended
March 31,
March 31,
2025
2024
Service-based RSUs
$
947
$
894
Performance and Market-based RSUs
485
154
Cash-settled RSUs
215
173
Total
$
1,647
$
1,221
Income tax benefit
387
279
Net expense
$
1,260
$
942
The following table summarizes the unrecognized compensation expense related to unvested RSUs by type and the weighted-average period in which the expense is to be recognized:
Unrecognized
Compensation
Weighted-
Expense at
Average
March 31, 2025
Period (years)
Service-based RSUs
$
4,291
1.47
Performance and Market-based RSUs
4,901
2.24
Total
$
9,192
1.88
We recognize expense on a straight-line basis over the requisite service period for each separately vesting portion of the award as if the award was, in substance, multiple awards.
23
The following table summarizes the status of these plans as of
March 31, 2025:
2018 Plan
2014 Plan
2009 Plan
2004 Plan
Directors'
Plan
Awards originally available
2,500,000
1,500,000
3,400,000
6,500,000
N/A
Maximum potential awards outstanding
650,602
39,400
34,100
14,545
4,722
RSUs and cash-settled awards vested and released
769,871
—
—
—
—
Awards available for grant
1,079,527
—
—
—
—
Service-Based Restricted Stock Units
The following table summarizes the service-based RSU activity for the three months ended
March 31, 2025:
Units
Weighted
Average
Grant Date
Fair Value
Outstanding at December 31, 2024
322,847
$
34.06
Granted
43,578
48.15
Vested and released
(
54,811
)
40.33
Outstanding at March 31, 2025
311,614
$
34.92
Releasable at March 31, 2025
159,156
$
23.85
Performance-Based Restricted Stock Units
The following table summarizes the performance-based RSU activity for the three months ended
March 31, 2025:
Units
Weighted
Average
Grant Date
Fair Value
Outstanding at December 31, 2024
222,344
$
40.15
Granted
59,215
47.73
Attained by performance
40,549
37.93
Released
(
79,162
)
37.93
Forfeited
(
48,682
)
37.93
Outstanding at March 31, 2025
194,264
$
44.83
Releasable at March 31, 2025
—
$
—
24
Cash-Settled Restricted Stock Units
Cash-Settled RSUs entitle the holder to receive the cash equivalent of one share of common stock for each unit when the unit vests. These RSUs are issued to key employees residing in foreign locations as direct compensation. Generally, these RSUs vest over a three-year period. Cash-Settled RSUs are classified as liabilities and are remeasured at each reporting date until settled. At March 31, 2025 and December 31, 2024, we had
15,028
and
44,127
Cash-Settled RSUs outstanding, respectively. At March 31, 2025 and December 31, 2024
, liabilities of $
274
and $
608
, respectively, were included in accrued expenses and other liabilities on our Condensed Consolidated Balance Sheets.
NOTE 15 — Fair Value Measurements
The table below summarizes our financial assets and liabilities that were measured at fair value on a recurring basis at
March 31, 2025:
Asset (Liability) Carrying
Value at
March 31,
2025
Quoted Prices
in Active
Markets for
Identical
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Interest rate swaps
$
1,076
$
—
$
1,076
$
—
Foreign currency hedges
$
(
1,593
)
$
—
$
(
1,593
)
$
—
Cross-currency swap
$
(
226
)
$
—
$
(
226
)
$
—
Qualified replacement plan assets
$
10,695
$
10,695
$
—
$
—
Contingent consideration
$
(
6,866
)
$
—
$
—
$
(
6,866
)
The table below summarizes the financial assets and liabilities that were measured at fair value on a recurring basis at December 31, 2024:
Asset (Liability) Carrying
Value at
December 31,
2024
Quoted Prices
in Active
Markets for
Identical
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Interest rate swaps
$
1,503
$
—
$
1,503
$
—
Foreign currency hedges
$
(
2,992
)
$
—
$
(
2,992
)
$
—
Cross-currency swap
$
324
$
—
$
324
$
—
Qualified replacement plan assets
$
11,380
$
11,380
$
—
$
—
Contingent consideration
$
(
7,028
)
$
—
$
—
$
(
7,028
)
We use interest rate swaps to convert a portion of our Revolving Credit Facility’s outstanding balance from a variable rate of interest into a fixed rate and foreign currency forward contracts to hedge the effect of foreign currency changes on certain revenues and costs denominated in foreign currencies. The Company entered into a cross-currency swap agreement in order to manage its exposure to changes in interest rates related to foreign debt. These derivative financial instruments are measured at fair value on a recurring basis. The fair value of our interest rate swaps and foreign currency hedges were measured using standard valuation models using market-based observable inputs over the contractual terms, including forward yield curves, among others. There is a readily determinable market for these derivative instruments, but that market is not active and therefore they are classified within Level 2 of the fair value hierarchy.
The fair value of the contingent consideration requires significant judgment. The Company's fair value estimates used in the contingent consideration valuation are considered Level 3 fair value measurements. The fair value estimates were based on assumptions management believes to be reasonable, but that are inherently uncertain, including estimates of future revenues and timing of events and activities that are expected to take place.
A roll-forward of the contingent consideration is as follows:
25
Contingent
Consideration
Balance at December 31, 2024
$
7,028
Change in fair value
(
162
)
Balance at March 31, 2025
$
6,866
As of March 31, 2025, all contingent consideration was recorded in other long-term obligations on our Condensed Consolidated Balance Sheets.
Our long-term debt consists of the Revolving Credit Facility, which is recorded at its carrying value. There is a readily determinable market for our long-term debt and it is classified within Level 2 of the fair value hierarchy as the market is not deemed to be active. The fair value of long-term debt approximates its carrying value and was determined by valuing a similar hypothetical coupon bond and attributing that value to our long-term debt under the Revolving Credit Facility.
The qualified replacement plan assets consist of investment funds maintained for future contributions to the Company’s U.S. 401(k) program. The investments are Level 1 marketable securities and are recorded in Other Assets on our Condensed Consolidated Balance Sheets.
NOTE 16 — Income Taxes
The effective tax rates for the
three months ended March 31, 2025 and March 31, 2024 are as follows:
Three Months Ended
March 31,
March 31,
2025
2024
Effective tax rate
17.1
%
18.6
%
The decrease in the effective income tax rate is primarily attributed to a change in mix of earnings taxed at lower rates and the establishment of valuation allowances on certain tax credits in the first quarter of 2024. The first quarter 2024 and 2025 effective income tax rates were lower than the U.S. statutory federal income tax rate primarily due to foreign earnings that are taxed at lower rates and tax benefits recorded upon vesting of RSUs.
NOTE 17 — Segment Information
The Company designs, manufactures, and sells a broad line of sensors, connectivity components, and actuators across multiple end markets in North America, Asia, and Europe.
Our Chief Operating Decision Maker (“CODM”), who is our Chair, President and Chief Executive Officer
, analyzes the results of our business through
one
reportable segment.
Our CODM evaluates the operating results and performance through Net earnings, which are reported on the Consolidated Statements of Earnings. These financial metrics are used to view operating trends, perform analytical comparisons and benchmark performance between periods and to monitor budget-to-actual variances on a monthly basis. To manage operations and make decisions regarding resources, our CODM is regularly provided and reviews expense information at a consolidated level for our Cost of goods sold, Selling, general, and administrative expenses and Research and Development expenses, which are reported on the Consolidated Statements of Earnings. As part of our strategic planning and annual operating plan, a focus is on sales growth, diversification, and profitability. The measure of segment assets is reported on the Consolidated Balance Sheet as Total Assets, but the CODM does not use discrete balance sheet information in assessing performance and allocating resources.
26
Item 2. Management’s Discussion and Analysis of Fin
ancial Condition and
Results of Operations (“MD&A”)
(in thousands of dollars, except percentages and per share amounts)
The following discussion should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and notes included under Item 1, as well as our Consolidated Financial Statements and notes and related Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2024.
Overview
CTS is a global manufacturer of sensors, connectivity components, and actuators. CTS was established in 1896 as a provider of high-quality telephone products and was incorporated as an Indiana corporation in February 1929. Our principal executive offices are located in Lisle, Illinois.
We design, manufacture, and sell a broad line of sensors, connectivity components, and actuators primarily to original equipment manufacturers (“OEMs”), tier one suppliers for the aerospace and defense, industrial, medical, and transportation markets, and the U.S. Government. Our vision is to be a leading provider of sensing and motion devices as well as connectivity components, enabling an intelligent and seamless world. These devices are categorized by their ability to Sense, Connect or Move. Sense products provide vital inputs to electronic systems. Connect products allow systems to function in synchronization with other systems. Move products ensure required movements are effectively and accurately executed. We are committed to achieving our vision by continuing to invest in the development of products, technologies, and talent within these categories.
We operate manufacturing facilities in North America, Asia, and Europe. Sales and marketing are accomplished through our sales engineers. We also utilize independent manufacturers' representatives and distributors to extend our sales capability.
There is an increasing proliferation of sensing and motion applications within various markets we serve. In addition, the increasing connectivity of various devices to the internet results in greater demand for communication bandwidth and data storage, increasing the need for our connectivity products. Our success is dependent on the ability to execute our strategy to support these trends. We are subject to a number of challenges including, without limitation, periodic market softness, competition from other suppliers, changes in technology, changes in the economy generally, including inflationary and/or recessionary conditions and increased tariffs, as well as the ability to add new customers, launch new products or penetrate new markets. Many of these, and other risks and uncertainties relating to the Company and our business, are discussed in further detail in Item 1A. of our Annual Report on Form 10-K and other filings made with the SEC.
27
Results of Operations: First Quarter 2025 versus First Quarter 2024
The following table highlights changes in significant components of the Unaudited Condensed Consolidated Statements of Earnings for the quarters ended March 31, 2025 and March 31, 2024:
Three Months Ended
March 31, 2025
March 31, 2024
Percent
Change
Percentage of Net Sales –
2025
Percentage of Net Sales –
2024
Net sales
$
125,769
$
125,750
—
100.0
%
100.0
%
Cost of goods sold
79,220
80,660
(1.8
)
63.0
64.1
Gross margin
46,549
45,090
3.2
37.0
35.9
Selling, general and administrative expenses
23,623
22,260
6.1
18.8
17.7
Research and development expenses
6,190
6,601
(6.2
)
4.9
5.2
Restructuring charges
451
1,693
(73.4
)
0.4
1.3
Total operating expenses
30,264
30,554
(0.9
)
24.1
24.3
Operating earnings
16,285
14,536
12.0
12.9
11.6
Total other income (expense), net
(163
)
(878
)
(81.4
)
(0.1
)
(0.7
)
Earnings before income taxes
16,122
13,658
18.0
12.8
10.9
Income tax expense
2,755
2,539
8.5
2.2
2.0
Net earnings
$
13,367
$
11,119
20.2
%
10.6
%
8.8
%
Earnings per share:
Diluted net earnings per share
$
0.44
$
0.36
Net sales were $125,769 in the first quarter of 2025, essentially flat with the first quarter of 2024. Net sales to the diversified end markets increased $8,046 or 13.6% while net sales to transportation markets decreased $8,027 or 12.1%. The SyQwest acquisition added net sales of $2,987. Changes in foreign exchange rates also decreased net sales by $835 year-over-year primarily due to the U.S. Dollar appreciating compared to the Euro.
Gross margin was $46,549 in the first quarter of 2025, an increase of $1,459 or 3.2% from the first quarter of 2024. The increase in gross margin was primarily driven by improved mix of sales by end market. Changes in foreign exchange rates increased gross margin by $1,739 year-over-year primarily due to the U.S. Dollar depreciating compared to the Mexican Peso. Losses from our hedges partially offset the positive foreign exchange impact. See Note 11, “Derivative Financial Instruments” in the Notes to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for further information. As a result, our gross margin percentage increased from 35.9% for the first quarter of 2024 to 37.0% for the first quarter of 2025.
Selling, general and administrative (“SG&A”) expenses were $23,623 or 18.8% of net sales in the first quarter of 2025, versus $22,260 or 17.7% of net sales in the first quarter of 2024. The increase in SG&A expenses as a percentage of net sales was primarily driven by higher depreciation and amortization expense in the first quarter of 2025. The SyQwest acquisition added additional depreciation and amortization expense of $1,378.
Research and development (“R&D”) expenses were $6,190 or 4.9% of net sales in the first quarter of 2025 compared to $6,601 or 5.2% of net sales in the first quarter of 2024. Our R&D expenses are in line with our commitment to continue investing in research and product development to drive organic growth.
Restructuring charges were $451 or 0.4% of net sales in the first quarter of 2025 compared to $1,693 or 1.3% of net sales in the first quarter of 2024. The restructuring charges in the quarter ended March 31, 2025 were primarily related to headcount reductions in response to softening demand in the transportation end market. See Note 7, “Costs Associated with Exit and Restructuring Activities” in the Notes to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for further information.
28
Other income and expense items are summarized in the following table:
Three Months Ended
March 31,
March 31,
2025
2024
Interest expense
$
(1,167
)
$
(801
)
Interest income
447
1,386
Other income (expense), net
557
(1,463
)
Total other expense, net
$
(163
)
$
(878
)
Interest income decreased due to lower investments of available cash into short-term, cash equivalent, high-yield deposit accounts as a result of the SyQwest acquisition in the third quarter of 2024. Interest expense increased due to higher borrowings to fund the SyQwest acquisition.
Three Months Ended
March 31,
March 31,
2025
2024
Effective tax rate
17.1
%
18.6
%
Our effective income tax rate was 17.1% and 18.6% in the first quarters of 2025 and 2024, respectively. The decrease in the effective income tax rate is primarily attributed to a change in mix of earnings taxed at lower rates and the establishment of valuation allowances on certain tax credits in the first quarter of 2024.
Liquidity and Capital Resources
We historically have funded our capital and operating needs primarily through cash flows from operating activities, supported by available credit under our Revolving Credit Facility (as defined below). We believe that cash flows from operating activities and available borrowings under our Revolving Credit Facility will be adequate to fund our working capital needs, capital expenditures, investments, and debt service requirements for at least the next twelve months and for the foreseeable future thereafter. However, we may choose to pursue additional equity and debt financing to provide additional liquidity or to fund acquisitions.
Cash and cash equivalents were $90,288 at March 31, 2025, and $94,334 at December 31, 2024, of which $89,210 and $92,944, respectively, were held outside the United States. Total long-term debt was $86,700 as of March 31, 2025 and $92,300 as of December 31, 2024.
Cash Flow Overview
Cash Flows from Operating Activities
Net cash provided by operating activities was $15,518 during the three months ended March 31, 2025. Components of net cash provided by operating activities included net earnings of $13,367, depreciation and amortization expense of $8,494, other net non-cash items of $1,339, and a net cash outflow from changes in assets and liabilities of $7,682.
Net cash provided by operating activities was $18,311 during the three months ended March 31, 2024. Components of net cash provided by operating activities included net earnings of $11,119, depreciation and amortization expense of $7,325, other net non-cash items of $132, and a net cash outflow from changes in assets and liabilities of $265.
Cash Flows from Investing Activities
Net cash used in investing activities for the three months ended March 31, 2025 and the three months ended March 31, 2024 were $4,465 and $4,035, respectively. Capital expenditures made up the investing activities for both periods.
Cash Flows from Financing Activities
29
Net cash used in financing activities for the three months ended March 31, 2025 was $15,900. The net cash outflow was the result of treasury stock purchases of $6,465 (net of excise taxes unpaid), dividends paid of $1,201, taxes paid on behalf of equity award participants of $2,634, and net cash used in the paydown of long-term debt of $5,600.
Net cash used in financing activities for the three months ended March 31, 2024 was $16,308. The net cash outflow was the result of treasury stock purchases of $11,958 (net of excise tax), dividends paid of $1,233, and taxes paid on behalf of equity award participants of $3,117.
Capital Resources
Revolving Credit Facility
Long‑term debt is comprised of the following:
As of
March 31,
December 31,
2025
2024
Total credit facility
$
400,000
$
400,000
Balance outstanding
86,700
92,300
Standby letters of credit
1,640
1,640
Amount available, subject to covenant restrictions
$
311,660
$
306,060
On December 15, 2021, we entered into a second amended and restated five-year credit agreement with a group of banks (the “Revolving Credit Facility”) to (i) increase the total credit facility availability to $400,000, which may be increased by $200,000 at the request of the Company, subject to the administrative agent's approval, (ii) extend the maturity of the Revolving Credit Facility from February 12, 2024 to December 15, 2026, (iii) replace LIBOR with SOFR as the primary reference rate used to calculate interest on the loans under the Revolving Credit Facility, (iv) increase available sub limits for letters of credit, and swingline loans as well as providing for additional alternative currency borrowing capabilities, and (v) modify the financial and non-financial covenants to provide the Company additional flexibility. This new unsecured credit facility replaced the prior $300,000 unsecured credit facility, which would have expired on February 12, 2024.
Borrowings in U.S. Dollars under the Revolving Credit Facility bear interest, at a per annum rate equal to the applicable Term SOFR rate (but not less than 0.0%), plus the Term SOFR adjustment, and plus an applicable margin, which ranges from 1.00% to 1.75%, based on our net leverage ratio. Similarly, borrowings of alternative currencies under the Revolving Credit Facility bear interest equal to a defined risk-free reference rate, plus the applicable risk-free rate adjustment and plus an applicable margin, which ranges from 1.00% to 1.75%, based on our net leverage ratio. We use interest rate swaps to convert a portion of our revolving credit facility's outstanding balance from a variable rate of interest to a fixed rate. The contractual rate of these arrangements ranges from 1.49% to 2.45%.
The Revolving Credit Facility includes a swingline sublimit of $20,000 and a letter of credit sub limit of $20,000. We also pay a quarterly commitment fee on the unused portion of the Revolving Credit Facility. The commitment fee ranges from 0.175% to 0.25% based on our net leverage ratio. We were in compliance with all debt covenants at March 31, 2025.
Critical Accounting Policies and Estimates
The Company’s Condensed Consolidated Financial Statements are prepared in accordance with U.S. GAAP. In connection with the preparation of the Condensed Consolidated Financial Statements, the Company uses estimates and makes judgments and assumptions about future events that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures. The assumptions, estimates, and judgments are based on historical experience, current trends, and other factors the Company believes are relevant at the time it prepares the Condensed Consolidated Financial Statements.
The critical accounting policies and estimates are consistent with those discussed in Note 1, “Summary of Significant Accounting Policies,” to the Consolidated Financial Statements and the MD&A section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. During and as of the three months ended March 31, 2025, there were no significant changes in the application of critical accounting policies or estimates.
30
Significant Customers
Our net sales to customers representing at least 10% of total net sales is as follows:
Three Months Ended
March 31, 2025
March 31, 2024
Toyota Motor Corporation
11.9
%
13.3
%
Cummins Inc.
10.3
%
13.6
%
No other customer accounted for 10% or more of total net sales during these periods.
Forward
‑
Looking Statements
Readers are cautioned that the statements contained in this document regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are, or may be deemed to be, “forward-looking statements” as defined by the “safe harbor” provisions in the Private Securities Litigation Reform Act of 1995. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, included or incorporated in this document, including statements regarding our strategy, financial position, guidance, funding for continued operations, cash reserves, liquidity, projected costs, plans, projects, awards and contracts, and objectives of management, among others, are forward-looking statements. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “continued,” “project,” “plan,” “goals,” “opportunity,” “appeal,” “estimate,” “potential,” “predict,” “demonstrates,” “may,” “will,” “might,” “could,” “intend,” “shall,” “possible,” “would,” “approximately,” “likely,” “outlook,” “schedule,” “on track,” “poised,” “pipeline,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not guarantees of future performance, conditions or results. Forward-looking statements are based on management’s expectations, certain assumptions, and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties, and other factors, which could cause CTS’ actual results, performance, or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: supply chain disruptions; changes in the economy generally, including inflationary and/or recessionary conditions and increased tariffs, and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions including, without limitation the integration of SyQwest; the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; risks associated with CTS’ international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks (including, without limitation, the impact of tariffs on China, Canada and Mexico, and other nations, the potential impact of U.S./China relations and the impact of the conflict between Russia and Ukraine may have on our business, results of operations and financial condition); the amount and timing of any share repurchases; and the effect of any cybersecurity incidents on our business. Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS’ most recent Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.
31
Item 3.
Quantitative and Qualita
tive Disclosures About Market Risk
See Item 7A, Quantitative and Qualitative Disclosures about Market Risk, of our Annual Report on Form 10-K for the year ended December 31, 2024. During the three months ended March 31, 2025, there have been no material changes in our exposure to market risk.
Item 4.
Control
s and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q were effective in providing reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within CTS have been detected.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting for the quarter ended March 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHE
R INFORMATION
Item 1.
Legal
Proceedings
From time to time, we are involved in litigation with respect to matters arising from the ordinary conduct of our business, and currently certain claims are pending against us. In the opinion of management, we believe we have established adequate accruals pursuant to U.S. generally accepted accounting principles for our expected future liability with respect to pending lawsuits, claims and proceedings, where the nature and extent of any such liability can be reasonably estimated based on presently available information. However, there can be no assurance that the final resolution of any existing or future lawsuits, claims or proceedings will not have a material adverse effect on our business, results of operations, financial condition, or cash flows.
See Note 9, “Commitments and Contingencies” in the Notes to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.
Item 1A.
Ri
sk Factors
In the first quarter of 2025, there were significant changes to tariffs by the U.S. and other countries. The tariff modifications are at various rates, with exemptions applicable to some categories of imports and exports. We are managing tariff-related impacts with a focus on agility in adapting to cost and price adjustments. The Company’s management continues to monitor and evaluate the ongoing situation, with plans formulated to respond to a varied range of potential market scenarios. Additional tariffs or future changes to the U.S.’s or other countries’ trade relations could further impact our business.
32
There have been no other changes to our risk factors from those contained in our Annual Report on Form 10-K for the year ended December 31, 2024.
Item 2.
Unregistered Sales of Equi
ty and Use of Proceeds
On February 2, 2024, the Board of Directors approved a new share repurchase program that authorizes the Company to repurchase up to $100 million of its common stock. The share repurchase program has no set expiration date and supersedes and replaces the repurchase program approved by the Board of Directors in February 2023.
Total Number
Maximum Dollar
of Shares
Value of Shares
Purchased as
That May Yet Be
Total Number
Part of Publicly
Purchased Under
of Shares
Average Price
Announced
Publicly Announced
Period
Purchased
Paid per Share
Programs
Plans or Programs
January 1, 2025 - January 31, 2025
35,000
$
51.91
35,000
$
57,864,043
February 1, 2025 - February 28, 2025
26,541
$
48.04
26,541
$
56,047,170
March 1, 2025 - March 31, 2025
82,000
$
43.39
82,000
$
54,772,056
Total
143,541
143,541
Item 5.
Other Information
From time to time, our directors and officers may purchase or sell shares of our common stock in the market, including pursuant to plans intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (“Rule 10b5-1 Plans”).
Ashish Agrawal, Vice President and Chief Financial Officer, entered into a Rule 10b5-1 Plan on February 27, 2025 for the sale of up to 25,000 shares of our common stock. The plan is scheduled to terminate no later than May 29, 2026.
During the quarter ended March 31, 2025
, no other director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company
adopted
,
modified
or
terminated
a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408 of Regulation S-K).
The following information from CTS Corporation’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 formatted in Inline XBRL: (i) Condensed Consolidated Statements of Earnings; (ii) Condensed Consolidated Statements of Comprehensive Earnings; (iii) Condensed Consolidated Balance Sheets; (iv) Condensed Consolidated Statements of Cash Flows; (v) Condensed Consolidated Statements of Shareholders’ Equity; (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
104
The cover page from this Current Report on Form 10-Q formatted as inline XBRL
34
SIGNAT
URES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CTS Corporation
/s/ Ashish Agrawal
Ashish Agrawal
Vice President and Chief Financial Officer
(Principal Financial Officer & Principal Accounting Officer)
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)